ClinicalTrials HQ

(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Active, not recruiting · NCT05607004 · Registry updated 2026-07-08
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, invasive breast carcinoma, neoplasm, skin disorderActive, not recruitingPhase 22026-07-08NCT05607004

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Atossa Therapeutics, Inc.2
InClin, Inc.2

14 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Avera Cancer InstituteSioux FallsUnited States140
Baylor UniversityHoustonUnited States1
Bon Secours Cancer InstituteMidlothianUnited States1
California Research InstituteLos AngelesUnited States15
Fred Hutchinson Cancer CenterSeattleUnited States250
Henry Ford Cancer InstituteDetroitUnited States18
Mayo Clinic ArizonaPhoenixUnited States55
Mayo Clinic FloridaJacksonvilleUnited States105
Mayo Clinic RochesterRochesterUnited States133
Northwestern UniversityChicagoUnited States727
St. Elizabeth HealthcareEdgewoodUnited States21
University of ArizonaTucsonUnited States18
Vanderbilt Ingram Cancer CenterNashvilleUnited States1
Washington University School of MedicineSt LouisUnited States895